These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 11423988)

  • 1. Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.
    Bessa M; Saville MK; Watson RJ
    Oncogene; 2001 Jun; 20(26):3376-86. PubMed ID: 11423988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties.
    Saville MK; Watson RJ
    Oncogene; 1998 Nov; 17(21):2679-89. PubMed ID: 9840932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-Myb repressor function is regulated by cyclin A phosphorylation and sequences within the C-terminal domain.
    Petrovas C; Jeay S; Lewis RE; Sonenshein GE
    Oncogene; 2003 Apr; 22(13):2011-20. PubMed ID: 12673206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
    Morris L; Allen KE; La Thangue NB
    Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-Myb overcomes a p107-mediated cell proliferation block by interacting with an N-terminal domain of p107.
    Joaquin M; Bessa M; Saville MK; Watson RJ
    Oncogene; 2002 Nov; 21(52):7923-32. PubMed ID: 12439743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PARP co-activates B-MYB through enhanced phosphorylation at cyclin/cdk2 sites.
    Santilli G; Cervellera MN; Johnson TK; Lewis RE; Iacobelli S; Sala A
    Oncogene; 2001 Dec; 20(57):8167-74. PubMed ID: 11781832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-Myb function can be markedly enhanced by cyclin A-dependent kinase and protein truncation.
    Lane S; Farlie P; Watson R
    Oncogene; 1997 May; 14(20):2445-53. PubMed ID: 9188859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the cyclin D1 and cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites.
    Bartusel T; Schubert S; Klempnauer KH
    Gene; 2005 May; 351():171-80. PubMed ID: 15922873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An alternatively spliced isoform of B-Myb is a transcriptional inhibitor.
    Horstmann S; Ferrari S; Klempnauer KH
    Oncogene; 2000 Nov; 19(48):5428-34. PubMed ID: 11114719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of the co-activator CBP with Myb proteins: effects on Myb-specific transactivation and on the cooperativity with NF-M.
    Oelgeschläger M; Janknecht R; Krieg J; Schreek S; Lüscher B
    EMBO J; 1996 Jun; 15(11):2771-80. PubMed ID: 8654374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain.
    Joaquin M; Watson RJ
    J Biol Chem; 2003 Nov; 278(45):44255-64. PubMed ID: 12947099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The C-terminal regulatory domain of p53 contains a functional docking site for cyclin A.
    Luciani MG; Hutchins JR; Zheleva D; Hupp TR
    J Mol Biol; 2000 Jul; 300(3):503-18. PubMed ID: 10884347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-cycle regulation of B-Myb protein expression: specific phosphorylation during the S phase of the cell cycle.
    Robinson C; Light Y; Groves R; Mann D; Marias R; Watson R
    Oncogene; 1996 May; 12(9):1855-64. PubMed ID: 8649845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redundant functions of B-Myb and c-Myb in differentiating myeloid cells.
    Golay J; Broccoli V; Borleri GM; Erba E; Faretta M; Basilico L; Ying GG; Piccinini G; Shapiro LH; Lovrić J; Nawrath M; Mölling K; Rambaldi A; Introna M
    Cell Growth Differ; 1997 Dec; 8(12):1305-16. PubMed ID: 9419419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linking Myb to the cell cycle: cyclin-dependent phosphorylation and regulation of A-Myb activity.
    Ziebold U; Klempnauer KH
    Oncogene; 1997 Aug; 15(9):1011-9. PubMed ID: 9285555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-Myb and cyclin D1 mediate heat shock element dependent activation of the human HSP70 promoter.
    Kamano H; Klempnauer KH
    Oncogene; 1997 Mar; 14(10):1223-9. PubMed ID: 9121772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of cyclin A/Cdk2 phosphorylation sites in B-Myb.
    Bartsch O; Horstmann S; Toprak K; Klempnauer KH; Ferrari S
    Eur J Biochem; 1999 Mar; 260(2):384-91. PubMed ID: 10095772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of transcription factors c-Myc, Max, and c-Myb by casein kinase II.
    Bousset K; Oelgeschläger MH; Henriksson M; Schreek S; Burkhardt H; Litchfield DW; Lüscher-Firzlaff JM; Lüscher B
    Cell Mol Biol Res; 1994; 40(5-6):501-11. PubMed ID: 7735324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of beta3-endonexin mutants for their ability to interact with cyclin A.
    Ohtoshi A; Otoshi H
    Mol Genet Genomics; 2001 Dec; 266(4):664-71. PubMed ID: 11810239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical interaction between CDK9 and B-Myb results in suppression of B-Myb gene autoregulation.
    De Falco G; Bagella L; Claudio PP; De Luca A; Fu Y; Calabretta B; Sala A; Giordano A
    Oncogene; 2000 Jan; 19(3):373-9. PubMed ID: 10656684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.